[Billing Code: 4140-01-P] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel Clinical Trial Readiness for Rare Diseases Date: September 5, 2024 Time: 10:00 AM to 2:00 PM Agenda: To review and evaluate grant applications Place: National Center for Advancing Translational Sciences National Institutes of Health 9609 Medical Center Drive Rockville, MD 20892 (Virtual Meeting) Contact Person: Alumit Ishai, PHD Scientific Review Officer Office of Grants Management and Scientific Review National Center for Advancing Translational Sciences National Institutes of Health 6701 Democracy Boulevard, MSC 4874 Bethesda, MD 20892 (301) 496-9539 alumit.ishai@nih.gov (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B - Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: June 6, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024-12837 Filed: 6/11/2024 8:45 am; Publication Date: 6/12/2024]